Presentation · Oct 2026 · PDF
Science
Explore conditions, clinical trials, and the latest research.
These pages contain non-exhaustive scientific information about uses of products that have not yet been approved by regulatory authorities, as their efficacy and safety for these uses have not yet been established. The information is provided for educational and scientific exchange purposes, and does not suggest products should be used in a manner not consistent with their respective label approved by the regulatory authorities, which may differ by geography. Any publication reflects the state of knowledge at the time it was published. The information is not medical advice and cannot replace the independent medical judgement of a healthcare professional.
Presentation · Oct 2026 · PDF
BBIO-Acoramidis-HFSA-2026-Females in ATTRibute-CMCVMCVH and NT-proBNP by sex-Davis
Presentation · Oct 2026 · PDF
BBIO-Acoramidis-HFSA-2026-ASCEND-ATTR Study Design-Masri
Presentation · Oct 2026 · PDF
BBIO-Acoramidis-HFSA-2026-CVH Mortality Risk-Bui
Presentation · Oct 2026 · PDF
BBIO-Acoramidis-HFSA-2026-DLDCVH-Wright
Presentation · Oct 2026 · PDF
BBIO-Acoramidis-HFSA-2026-KCCQ Domains by genotype-Sarswat
Presentation · Oct 2026 · PDF
BBIO-Encaleret-ASBMR-2026-CALIBRATE Baseline Symptoms-Ing
Presentation · Oct 2026 · PDF
BBIO-Encaleret-ASBMR-2026-Genetic Testing events-Warren
Presentation · Oct 2026 · PDF
BBIO-Acoramidis-HFSA-2026-Falls fractures and HCRU-Hasan-Sarwat
Presentation · Sep 2026 · PDF